Cell viability was detected by the MTT assay (Sigma-Aldrich; Merck KGaA). HCT116 and SW620 cells were digested, dispersed and inoculated in 96-well plates at a density of 1×104 cells/well and 2×104 cells/well, respectively. The cells were cultured in complete DMEM and incubated in a 37°C incubator containing 5% CO2. After cells were allowed to proliferate for 24 h, RPMTG at different concentrations (0, 100, 200, 250, 300, 400 and 500 µg/ml) was added; after 12 and 24 h, 15 µl MTT was added into each well of the blank group and the RPMTG treatment group; after a further 4 h, DMSO was added, and the plates were analysed at 490 nm on a microplate reader (Thermo Fisher Scientific, Inc.). The ratio of cell survival was calculated against that of the untreated CRC cell group.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.